[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"plantar-fasciitis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:plantar-fasciitis":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,22,0,[8,46,72,99,123,156,183,205,227,251,276,297,322,346,371,392,416,436,466,493,519,541],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100053865","ice-packs-versus-cold-baths-combined-with-standard-exercise-therapy-for-plantar-fasciitis-100053865",false,"NCT07694999","Ice Packs Versus Cold Baths Combined With Standard Exercise Therapy for Plantar Fasciitis","Comparative Efficacy of Ice Packs Versus Cold Baths With Standard Exercise Therapy in the Management of Plantar Fasciitis","Inclusion Criteria:\n\n* Adults aged 18 to 65 years.\n* Clinical diagnosis of unilateral or bilateral Plantar Fasciitis.\n* Heel pain localized to the medial calcaneal tubercle.\n* Positive Windlass test.\n* Pain intensity of ≥4 on the Visual Analogue Scale (VAS) at baseline.\n* Willing and able to provide written informed consent.\n* Willing to comply with the study protocol and attend all treatment and assessment sessions.\n\nExclusion Criteria:\n\n* History of foot or ankle surgery within the previous 6 months.\n* Corticosteroid injection for plantar fasciitis within the previous month.\n* Neurological disorders affecting the lower limb.\n* Peripheral vascular disease or other vascular disorders affecting the lower limb.\n* Open wounds, skin infections, or contraindications to cryotherapy.\n* Pregnancy.\n* Participation in another interventional clinical trial during the study period.\n* Inability to follow the study protocol or complete outcome assessments.","ALL","18 Years","65 Years",{"count":20,"type":21},40,"ESTIMATED","INTERVENTIONAL",[24],"NA","This randomized controlled trial aims to compare the effectiveness of ice pack therapy and cold bath immersion when combined with standard exercise therapy in adults with plantar fasciitis. Plantar fasciitis is a common cause of heel pain that can limit daily activities and reduce quality of life. Participants will be randomly assigned to receive either ice pack therapy or cold bath therapy in addition to the same standardized exercise program. The primary outcome will be pain intensity measured using the Visual Analogue Scale (VAS), and the secondary outcome will be foot function measured using the Foot Function Index (FFI). The findings of this study may help identify the more effective cryotherapy method for reducing pain and improving function in individuals with plantar fasciitis.",[27],"Plantar Fasciitis",[29,30,31,32],"Ice Pack","Cold Bath","Foot Function Index","Visual Analogue Scale","RECRUITING","2026-07-10",{"date":36,"type":37},"2026-07-13","ACTUAL",{"date":39,"type":37},"2026-02-17",{"date":41,"type":21},"2026-07-07",{"name":43,"class":44},"Ibadat International University, Islamabad","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":53,"minAge":54,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":22,"phases":58,"briefSummary":59,"conditions":60,"keywords":61,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":68,"leadSponsor":70,"locationsCount":45},"100644970","comparative-effects-of-myofascial-release-and-instrument-assisted-soft-tissue-moblization-in-pregnant-women-with-plantar-fasciitis-100644970","NCT07676058","Comparative Effects of Myofascial Release and Instrument Assisted Soft Tissue Moblization in Pregnant Women With Plantar Fasciitis","MFR-IASM-PF","Inclusion Criteria:\n\n* Pregnant women aged 20-40 years.\n* In the second and third trimester of pregnancy (gestational weeks 12-34).\n* Clinically diagnosed with plantar fasciitis, with symptoms of heel pain at the medial calcaneal insertion of the plantar fascia.\n* The pain is most intense with the first few steps in the morning or after prolonged rest. Positive findings from a Windlass test or palpation-provoked pain indicating plantar fasciitis.\n\nExclusion Criteria:\n\n* Known foot fractures or significant foot deformities.\n* Systemic inflammatory diseases (e.g., rheumatoid arthritis) that may affect tissue healing and response to therapy.\n* Active obstetric complications that contraindicate physiotherapy.\n* Recent corticosteroid injections to the heel (\\\u003C6 months prior).\n* Inability or unwillingness to comply with follow-up visits or the intervention protocol.","FEMALE","20 Years","40 Years",{"count":57,"type":21},44,[24],"Plantar fasciitis is a common musculoskeletal disorder characterized by heel pain and functional limitations, which may become more pronounced during pregnancy due to weight gain, hormonal changes, and altered biomechanics. Conservative physiotherapy interventions are commonly used to manage symptoms; however, evidence regarding the comparative effectiveness of different manual therapy techniques in pregnant women remains limited.\n\nThis randomized clinical trial aims to compare the effects of Myofascial Release (MFR) and Instrument-Assisted Soft Tissue Mobilization (IASTM) on pain intensity and foot function in pregnant women diagnosed with plantar fasciitis. A total of 44 pregnant women aged 20-40 years in their second or third trimester will be recruited and randomly allocated into two treatment groups. Both groups will receive baseline treatment consisting of therapeutic ultrasound, gastrocnemius and soleus stretching exercises, tibialis anterior strengthening, and a home exercise program. In addition, Group A will receive Myofascial Release, while Group B will receive Instrument-Assisted Soft Tissue Mobilization.\n\nThe intervention will be delivered over a period of four weeks, with three supervised sessions per week. Pain intensity will be assessed using the Numerical Pain Rating Scale (NPRS), while foot-related pain, disability, and functional limitations will be measured using the Foot Function Index (FFI). Outcomes will be evaluated at baseline and after completion of the intervention.\n\nThe findings of this study are expected to provide evidence regarding the most effective manual therapy approach for reducing pain and improving functional outcomes in pregnant women suffering from plantar fasciitis.",[27],[27,62,63],"Myofascial Release","Instrument-Assisted Soft Tissue Mobilization","2026-06-23",{"date":66,"type":37},"2026-06-30",{"date":66,"type":21},{"date":69,"type":21},"2026-07-31",{"name":71,"class":44},"University of Lahore",{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":79,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":80,"targetDuration":4,"studyType":82,"phases":4,"briefSummary":83,"conditions":84,"keywords":85,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":45},"100642747","relationship-between-central-sensitization-and-clinical-features-in-plantar-fasciitis-100642747","NCT07640620","Relationship Between Central Sensitization and Clinical Features in Plantar Fasciitis","IInvestigation of the Relationship Between Central Sensitization and Clinical, Functional, and Ultrasonographic Parameters In Plantar Fasciitis","Plantar Fasciitis Group\n\n1. Inclusion criteria\n\n   * Be between the ages of 18-65\n   * Have unilateral heel pain that has been ongoing for at least 3 months, particularly worsening with the first few steps in the morning and increasing with weight-bearing activities throughout the day\n   * Have tenderness on palpation of the medial calcaneal tubercle\n   * Have read and signed the volunteer consent form (VCF)\n2. Exclusion criteria\n\n   * Being under 18 years old or over 65 years old\n   * Having a history of physical therapy, injection, radiation, or surgery targeting the plantar fascia within the last 6 months\n   * Calcaneus fracture, tumor, or cyst related to the plantar fascia\n   * Foot deformity (club foot, pes cavus, calcaneovalgus, etc.)\n   * Lumbosacral radiculopathy, tarsal tunnel syndrome, peripheral neuropathy\n   * Rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, gout\n   * Foot and ankle osteoarthritis\n   * Presence of osteomyelitis or skin infection in the foot\n   * Systemic diseases such as kidney and liver failure, diabetes, peripheral arterial vascular disease\n\nHealthy Control\n\n1. Inclusion criteria\n\n   * Being completely healthy\n   * Being between the ages of 18 - 65\n   * Having read and signed the volunteer consent form (BGOF)\n2. Exclusion criteria\n\n   * Being under 18 or over 65 years old\n   * Having any acute or chronic illness\n   * Being illiterate and not giving consent to participate in the study",true,{"count":81,"type":21},128,"OBSERVATIONAL","Plantar fasciitis is a common cause of heel pain and is traditionally considered a mechanical musculoskeletal disorder. Recent evidence suggests that central sensitization may also contribute to pain in individuals with plantar fasciitis. This study aims to investigate the relationships between neurophysiological variables (pressure pain threshold, central sensitization, and pain intensity), psychological factors (pain catastrophizing, kinesiophobia, anxiety, and depression), ultrasonographic findings (plantar fascia thickness), and functional outcomes (foot function and quality of life) in patients with plantar fasciitis.",[27],[86,87,88,89],"plantar fasciitis","central sensitization","pain pressure threshold","kinesiophobia","2026-06-05",{"date":92,"type":37},"2026-06-11",{"date":94,"type":37},"2026-04-07",{"date":96,"type":21},"2026-09-20",{"name":98,"class":44},"Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey",{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":4,"eligibilityCriteria":105,"healthyVolunteers":79,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":106,"targetDuration":4,"studyType":22,"phases":108,"briefSummary":109,"conditions":110,"keywords":4,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":114,"lastUpdatePostDateStruct":115,"startDateStruct":117,"completionDateStruct":119,"leadSponsor":121,"locationsCount":45},"100637975","eswt-in-the-treatment-of-plantar-fasciitis-100637975","NCT07626723","ESWT in the Treatment of Plantar Fasciitis","The Effect of ESWT Session Count on Clinical Parameters in the Treatment of Chronic Plantar Fasciitis; Randomized Controlled Study","Inclusion Criteria:\n\n* Patients aged 18-65, both male and female, diagnosed with plantar fasciitis based on anamnesis and physical examination.\n* Patients must have had symptoms for at least 3 months.\n* Patients must consent to participate in the study according to the informed consent form.\n\nExclusion Criteria:\n\n* Complaint lasting less than 3 months\n* Having received an injection in the heel area within the last 6 months\n* Having applied physical therapy modalities to the heel area within the last 6 months\n* Bilateral complaint\n* Pregnancy\n* Malignancy\n* Epilepsy\n* History of cardiac pacemaker\n* Anticoagulant use\n* History of systemic inflammatory disease\n* History of fracture or surgery in the lower extremity\n* Presence of an open wound in the heel area\n* Hypersensitivity in the patient\n* Systemic infection in the patient\n* Uncontrolled hypertension in the patient\n* Uncontrolled diabetes in the patient\n* Inability of the patient to cooperate\n* History of neuromuscular disease affecting balance parameters\n* Patient's unwillingness to participate in the study",{"count":107,"type":21},57,[24],"Extracorporeal shock wave therapy (ESWT) has become widely preferred in Turkey and worldwide in recent years for the treatment of musculoskeletal diseases due to its non-invasive nature, ease of application, and low risk of complications, as it does not require surgical intervention. However, there is no consensus in the literature regarding the energy level used in ESWT applications, the frequency of application, and especially the ideal number of sessions. Different centers apply varying protocols in clinical practice, which can lead to heterogeneity in treatment outcomes. Scientifically determining the effect of variation in the number of ESWT sessions on clinical outcomes is important for establishing standard treatment protocols. Therefore, the aim of our study is to contribute to the existing literature by investigating the effect of variation in the number of ESWT sessions on clinical parameters such as pain, functional status, and quality of life in the treatment of chronic plantar fasciitis, and to develop more effective and evidence-based treatment approaches in patient management.",[27,111,112],"Extracorporeal Shock Wave Therapy","Ultrasonography","NOT_YET_RECRUITING","2026-06-01",{"date":116,"type":37},"2026-06-04",{"date":118,"type":21},"2026-07-01",{"date":120,"type":21},"2027-03-15",{"name":122,"class":44},"Kirsehir Ahi Evran Universitesi",{"id":124,"slug":125,"hasResults":11,"nctId":126,"briefTitle":127,"officialTitle":128,"acronym":4,"eligibilityCriteria":129,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":130,"enrollmentInfo":131,"targetDuration":4,"studyType":22,"phases":133,"briefSummary":134,"conditions":135,"keywords":139,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":45},"100638228","barefoot-walking-vs-standardised-conservative-care-for-plantar-fasciopathy-100638228","NCT07600229","Barefoot Walking VS Standardised Conservative Care for Plantar Fasciopathy","Clinical and Economic Effectiveness of Barefoot Walking Compared to Standardised Conservative Care for the Treatment of Plantar Fasciopathy: a Pragmatic Randomised Controlled Trial","Inclusion Criteria:\n\n* Aged 18-70 years;\n* Clinical diagnosis of Plantar Fasciopahty, defined by: a) Pain localised to the medial calcaneal tubercle of sharp or stabbing quality; b) Pain worst with the first few steps in the morning or after a period of rest (first-step pain); c) Pain reproduced with palpation of the medial calcaneal tubercle OR positive Windlass Test;\n* Symptom duration greater than 4 weeks;\n* Able to walk independently without a mobility aid\n* Able to provide informed consent and comply with study protocol\n\nExclusion Criteria:\n\n* Prior surgery on the affected foot\n* Diabetes with peripheral neuropathy or other neurological condition affecting lower limb sensation or motor control\n* Active inflammatory arthropathy, uncontrolled vascular disease, or inability to walk unaided\n* Current or recent (less than 6 months) bony stress fracture or other acute foot or ankle injury on the affected side\n* Pregnancy during the intervention period\n* BMI greater than 40 kg\u002Fm²\n* Corticosteroid injection to the affected foot within the previous 3 months\n* Night splints initiated less than 4 weeks prior to enrolment\n* Any condition that would make participation unsafe, including open foot wounds","70 Years",{"count":132,"type":21},74,[24],"The goal of this clinical trial is to learn if a barefoot walking programme can treat plantar fasciopathy (heel pain) in adults aged 18-70. The main questions it aims to answer are:\n\n* Does a barefoot walking programme reduce heel pain compared to a standardised stretching and strengthening programme?\n* Does a barefoot walking programme improve foot function and quality of life in adults with plantar fasciopathy?\n\nResearchers will compare a barefoot walking programme to a standardised stretching and strengthening programme to see if barefoot walking is an effective conservative management approach for plantar fasciopathy.\n\nParticipants will:\n\n* Be randomly assigned to either a barefoot walking programme or a stretching and strengthening programme\n* Complete a 12-week home-based exercise programme\n* Complete short weekly questionnaires throughout the 12 weeks\n* Complete 3 follow-up surveys over 6 months after the intervention ends\n* Receive education on load management and plantar fasciopathy",[136,27,137,138],"Plantar Fasciopathy","Plantar Fasciitis, Chronic","Heel Pain",[140,141,142,143,144,145,146],"Plantar fasciopathy","Plantar fasciitis","Heel pain","Barefoot walking","Foot pain","Musculoskeletal","Physical therapy","2026-05-20",{"date":149,"type":37},"2026-05-22",{"date":151,"type":37},"2026-05-07",{"date":153,"type":21},"2027-10-31",{"name":155,"class":44},"Elisabetta Brigo",{"id":157,"slug":158,"hasResults":11,"nctId":159,"briefTitle":160,"officialTitle":161,"acronym":4,"eligibilityCriteria":162,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":163,"enrollmentInfo":164,"targetDuration":4,"studyType":22,"phases":166,"briefSummary":168,"conditions":169,"keywords":171,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":174,"lastUpdatePostDateStruct":175,"startDateStruct":177,"completionDateStruct":179,"leadSponsor":181,"locationsCount":4},"100640707","phase-2-efficacy-of-extracorporeal-shockwave-therapy-on-plantar-fasciitis-in-patients-with-peripheral-neuropathy-100640707","NCT07587255","Efficacy of Extracorporeal Shockwave Therapy on Plantar Fasciitis in Patients With Peripheral Neuropathy","Efficacy of Extracorporeal Shockwave Therapy for Plantar Fasciitis in Patients With Peripheral Neuropathy: A Clinical Evaluation","Inclusion Criteria:\n\n* Age 18 or older and 90 or younger.\n* Ability to give informed consent.\n* Presence of peripheral neuropathy, confirmed by clinical symptoms, nerve\n* conduction study, autonomic function test, quantitative sensory test, or skin biopsy.\n* Plantar fasciitis presenting as (1) heel pain persisting for more than 3 months, most noticeable with initial steps after a period of inactivity, but also worse following prolonged weight-bearing, and (2) pain with palpation of the proximal insertion of the plantar fascia.\n\nExclusion Criteria:\n\n* Presence of severe systemic diseases, including severe ischemic heart disease or congestive heart failure (left ventricular ejection fraction \\\u003C 30%), severe lung diseases with dyspnea, severe generalized edema, uncontrolled diabetes, and systemic infection.\n* Presence of severe peripheral vascular disease.\n* Presence of an implanted cardiac pacemaker, deep brain stimulator, or metallic implants (for example, internal fixation plates, screws, etc.) within the affected foot or ankle.\n* Presence of ruptured or pre-ruptured tendons in the target area. A diagnostic softtissue ultrasound of the plantar foot will be performed to assess tissue integrity if any of the following clinical red flags are identified: localized soft-tissue swelling or ecchymosis; physical examination findings indicative of a loss of continuity or tension in the plantar fascia; a history of local corticosteroid injection within the past 12 months; or a history of surgical intervention involving the affected foot.\n* Complete loss of vibration and pinprick sensation at the target area due to neuropathy, or the presence of severe mechanical allodynia (pain evoked by friction or pressure) at the target area with an intensity score of 8 or higher on the Numeric Rating Scale (NRS), where 0 represents no pain and 10 represents the most severe pain.\n* Pregnancy.\n* Coagulation disorders (including localized thrombosis in the target area).\n* Patients currently receiving anticoagulant therapy.\n* Presence of localized tumors or active bacterial and\u002For viral infections in the target area.\n* Patients who have received corticosteroid injections within the past 6 weeks in the target area.\n* Inability to give informed consent.","90 Years",{"count":165,"type":21},114,[167],"PHASE2","This study aims to evaluate the efficacy of extracorporeal shockwave therapy (ESWT) in reducing pain and improving functional outcomes for patients with neuropathy-associated plantar fasciitis.",[170,27],"Neuropathic Pain",[172,173],"neuropathic pain","peripheral neuropathy","2026-05-12",{"date":176,"type":37},"2026-05-14",{"date":178,"type":21},"2026-05",{"date":180,"type":21},"2032-05",{"name":182,"class":44},"National Taiwan University Hospital",{"id":184,"slug":185,"hasResults":11,"nctId":186,"briefTitle":187,"officialTitle":188,"acronym":4,"eligibilityCriteria":189,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":190,"targetDuration":4,"studyType":22,"phases":192,"briefSummary":193,"conditions":194,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":196,"startDateStruct":198,"completionDateStruct":200,"leadSponsor":202,"locationsCount":45},"100455908","novel-stretching-device-versus-night-splints-100455908","NCT05216679","Novel Stretching Device Versus Night Splints","Novel Stretching Device Versus Night Splints a Prospective, Randomized Study in the Effectiveness of Treating Plantar Fasciitis","Inclusion Criteria:\n\n* age 18 years and older\n* diagnosis of plantar fasciitis\n* ability to understand the purpose of the study\n* ability to safely use the device they are assigned after education and return demonstration.\n\nExclusion Criteria:\n\n* patients with ankle fusion\n* significant balance impairment which would prohibit safe use of the AcuFlex device\n* corticosteroid injection within last 60 days\n* pregnancy",{"count":191,"type":21},100,[24],"A set of 100 patients previously diagnosed with plantar fasciitis will be given initial questionnaires about their symptoms and randomly assigned either night splints or the novel calf stretching device. The participants will use each device for 6 weeks. At the end of those 6 weeks, they will return for a follow up questionnaire. The answers in the questionnaire will be analyzed to compare the effectiveness of night splints to calf stretching.",[27],"2026-04-22",{"date":197,"type":37},"2026-04-28",{"date":199,"type":21},"2026-04-15",{"date":201,"type":21},"2026-12-01",{"name":203,"class":204},"SAE Orthopedics","INDUSTRY",{"id":206,"slug":207,"hasResults":11,"nctId":208,"briefTitle":209,"officialTitle":210,"acronym":211,"eligibilityCriteria":212,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":130,"enrollmentInfo":213,"targetDuration":4,"studyType":22,"phases":215,"briefSummary":216,"conditions":217,"keywords":4,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":218,"lastUpdatePostDateStruct":219,"startDateStruct":221,"completionDateStruct":223,"leadSponsor":225,"locationsCount":4},"100615011","a-single-blind-randomized-controlled-study-comparing-the-efficacy-of-high-intensity-laser-therapy-and-focused-extracorporeal-shock-wave-therapy-in-patients-with-plantar-fasciitis-100615011","NCT07287046","A Single-Blind Randomized Controlled Study Comparing the Efficacy of High-Intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patients With Plantar Fasciitis","A Comparison of Efficacy Between High-intensity Laser Therapy and Focused Extracorporeal Shock Wave Therapy in Patient With Plantar Fasciitis; Single Blinded Randomize Controlled Study","HILT","Inclusion Criteria:\n\n* Patients aged 18-70 years\n* Pain was worse in the initial step after and an extended period of rest\n* Pain was decreased initially after the first steps but exacerbated with increased activity\n* VAS ≥ 4\n* Pain was localized and sharp but not radiating,\n* Pain was reproduced with palpation of the plantar fascia\n\nExclusion Criteria:\n\n* Have Wound\u002FInfection\u002Ftumor in treatment area\n* History of foot trauma in 3 months\n* History of intervention at plantar fascia in 6 months such as Ultrasound therapy, steroid injection, surgery or botulinum toxin injection\n* Pain medication within one week before participation\n* Patient wasn't desired to participate in the study",{"count":214,"type":21},28,[24],"This randomized controlled trial aims to evaluate the efficacy of High-Intensity Laser Therapy (HILT) and Focused Extracorporeal Shock Wave Therapy (fESWT) in reducing pain in patients with plantar fasciitis. The study also examines the effects of HILT and fESWT on health-related outcomes, including VAS-FA, FFI, plantar fascia thickness, and adverse events.\n\nResearchers will compare HILT with fESWT as treatment options for patients with plantar fasciitis.\n\nParticipants will receive either HILT or fESWT along with an exercise program. They will attend follow-up visits to assess outcomes at 1, 2, 3, 6, and 12 weeks after the first treatment.",[27],"2026-03-20",{"date":220,"type":37},"2026-03-25",{"date":222,"type":21},"2026-02-28",{"date":224,"type":21},"2027-02-20",{"name":226,"class":44},"Mahidol University",{"id":228,"slug":229,"hasResults":11,"nctId":230,"briefTitle":231,"officialTitle":232,"acronym":4,"eligibilityCriteria":233,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":234,"targetDuration":4,"studyType":82,"phases":4,"briefSummary":236,"conditions":237,"keywords":240,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":242,"lastUpdatePostDateStruct":243,"startDateStruct":245,"completionDateStruct":247,"leadSponsor":249,"locationsCount":45},"100622433","effect-of-additional-sural-nerve-prf-in-chronic-heel-pain-100622433","NCT07383558","Effect of Additional Sural Nerve PRF in Chronic Heel Pain","Does Targeting the Sural Nerve in Addition to the Posterior Tibial Nerve Increase the Effectiveness of Pulsed Radiofrequency Treatment in Chronic Plantar Heel Pain?","Inclusion Criteria:\n\nAge between 18 and 65 years\n\nPresence of chronic plantar heel pain\n\nBaseline VAS score \\>5\n\nExclusion Criteria:\n\nHistory of foot fracture or tumor\n\nPregnancy\n\nCoagulopathy or use of antiplatelet therapy\n\nCognitive impairment preventing informed consent",{"count":235,"type":21},48,"This observational study aims to compare the effectiveness of pulsed radiofrequency (PRF) treatment applied to the posterior tibial nerve alone versus PRF applied to both the posterior tibial and sural nerves in patients with chronic plantar heel pain. Outcomes will be assessed using the Visual Analog Scale (VAS) and the American Orthopaedic Foot and Ankle Society (AOFAS) hindfoot score at baseline, 1 month, and 3 months after treatment.",[238,27,239],"Chronic Plantar Heel Pain","Spur, Heel",[241],"posterior tibial nerve, sural nerve, heel pain, plantar pain","2026-02-23",{"date":244,"type":37},"2026-02-25",{"date":246,"type":37},"2025-06-01",{"date":248,"type":21},"2026-09-01",{"name":250,"class":44},"Diskapi Teaching and Research Hospital",{"id":252,"slug":253,"hasResults":11,"nctId":254,"briefTitle":255,"officialTitle":256,"acronym":4,"eligibilityCriteria":257,"healthyVolunteers":11,"sex":16,"minAge":258,"maxAge":259,"enrollmentInfo":260,"targetDuration":4,"studyType":22,"phases":262,"briefSummary":264,"conditions":265,"keywords":266,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":267,"lastUpdatePostDateStruct":268,"startDateStruct":270,"completionDateStruct":272,"leadSponsor":274,"locationsCount":45},"100623322","phase-1-lateral-plantar-artery-embolization-for-plantar-fasciitis-100623322","NCT07395128","Lateral Plantar Artery Embolization For Plantar Fasciitis","Lateral Plantar Artery Embolization to Treat Pain Chronic Heel Pain Due To Plantar Fasciitis A Pilot Study to Assess Feasibility","Inclusion Criteria:\n\n* Age ≥ 25 years\n* Subject provides written informed consent\n* Patient with Plantar Fasciitis refractory to 3 months of conservative management\n* Self reported pain of at least 4\u002F10 on visual analog scale (VAS)\n* Non-surgical candidate\u002Flooking to avoid surgery\n\nExclusion Criteria:\n\n* Heel pain caused by acute fracture, recent trauma, inflammatory conditions, muscle\u002Fligament injury, and etiologies related to bone mineral density.\n* Steroid injection in the last 90 days from the embolization procedure\n* Known severe allergy to Lipiodol and\u002For iodinated contrast media\n* Diagnosis of peripheral arterial disease affecting the lower extremities\n* Pregnancy or breastfeeding\n* Anticoagulation or irreversible coagulopathy\n* GFR \\\u003C45 or Serum creatinine \\> 2.0 mg\u002Fdl\n* Type 1 Diabetes Mellitus","25 Years","80 Years",{"count":261,"type":21},10,[263],"PHASE1","The goal of this clinical trial is to learn if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain due to plantar fasciitis in adults aged 25 to 80. The main questions it aims to answer are:\n\nDoes this procedure successfully reduce chronic heel pain as measured by the Visual Analog Scale (VAS) over 12 months?\n\nHow safe is the procedure, specifically regarding the frequency of serious medical problems or adverse events related to the device?\n\nParticipants will:\n\nUndergo a minimally invasive procedure where a doctor uses a small tube (catheter) to inject a temporary blocking agent (LipioJoint) into specific blood vessels in the foot.\n\nReceive a phone call one day after the procedure to check for early side effects.\n\nParticipate in four follow-up telehealth visits over the course of one year (at 1, 3, 6, and 12 months).\n\nComplete pain intensity surveys (VAS) and report any changes in their use of other therapies or medications during these visits.",[137,27],[86],"2026-02-05",{"date":269,"type":37},"2026-02-09",{"date":271,"type":37},"2025-12-20",{"date":273,"type":21},"2027-03",{"name":275,"class":204},"Joint & Vascular Institute",{"id":277,"slug":278,"hasResults":11,"nctId":279,"briefTitle":280,"officialTitle":281,"acronym":4,"eligibilityCriteria":282,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":130,"enrollmentInfo":283,"targetDuration":4,"studyType":22,"phases":285,"briefSummary":286,"conditions":287,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":288,"lastUpdatePostDateStruct":289,"startDateStruct":291,"completionDateStruct":293,"leadSponsor":295,"locationsCount":45},"100615560","percutaneous-electrolysis-targeting-the-muscle-fascia-chain-for-treating-chronic-plantar-fasciitis-in-adults-100615560","NCT07294196","Percutaneous Electrolysis Targeting the Muscle-Fascia Chain for Treating Chronic Plantar Fasciitis in Adults","Effectiveness of Percutaneous Electrolysis Treatment Targeting the Muscle-Fascia Chain in Chronic Plantar Fasciitis: A Randomized Controlled Study","Inclusion Criteria:\n\nPatients who agree to participate in the study, are between 18 and 70 years of age, have had symptoms for at least 6 weeks, and have a diagnosis of plantar fasciitis confirmed clinically (sharp pain on the plantar surface of the foot upon standing after rest, heel pain that is most severe with the first steps in the morning and decreases with mild activity) and by ultrasonography (plantar fascia thickness recorded as \\>4 mm on ultrasound), who have not previously received any medical treatment for the condition, who agree not to use anti-inflammatory drugs during the treatment period, who have normal blood laboratory findings, who have no known acute or chronic inflammatory disease, who have a level of education sufficient to understand the treatment and procedures applied, and who are able to complete the treatment evaluation forms will be included in the study.\n\nExclusion Criteria:\n\nPatients with malignancy, active infection, a history of systemic inflammatory rheumatic disease, trauma, skin lesions, infection or open wounds on the foot, neuropathy, radiculopathy, peripheral circulatory disorders, coagulopathy, warfarin use, arthropathy, congenital or acquired lower extremity deformity, sequelae of lower extremity fracture, the presence of a prosthesis, internal plate or screw fixation, a cardiac pacemaker, a metal implant in the treatment area, conditions that contraindicate physiotherapy such as pregnancy, or metal allergy will not be included in the study.",{"count":284,"type":21},50,[24],"The aim of this study is to compare, in terms of treatment effectiveness, a control group receiving a combination of a conventional exercise program and percutaneous electrolysis applied to the plantar fascia with an intervention group receiving a combination of a conventional exercise program plus percutaneous electrolysis applied both to the plantar fascia and to myofascial trigger points in the gastrosoleus muscles. Patients participating in the study will be randomized into two groups. Both groups will receive a conventional home exercise program. In the intervention group, percutaneous electrolysis treatment will be applied to both the plantar fascia and the trigger points of the gastrosoleus muscles. In the control group, percutaneous electrolysis treatment will be applied only to the plantar fascia. The percutaneous electrolysis treatment protocol will be administered on the 1st, 8th and 14th days of treatment under ultrasound guidance, using 0.3-millimeter acupuncture needles and an EPTE® percutaneous electrolysis device (Ionclinics \\& A. Deionic SL, Valencia, Spain) at an intensity of 350 µA for 80 seconds. The conventional home exercise program will include plantar fascia and Achilles tendon stretching, ball or cylinder rolling, and towel-grasping exercises targeting the intrinsic foot muscles. Patients' subjective pain intensity will be assessed using the Visual Analog Scale (VAS), pressure pain threshold using an algometer, functional level using the Foot Function Index (FFI), tissue parameters using ultrasound, and maximum standing and walking times without heel pain; all outcomes will be measured and recorded before treatment, after treatment, and three months after the start of treatment. The aim of the study is to compare, in terms of treatment effectiveness, the control group receiving a combination of a conventional exercise program and percutaneous electrolysis applied to the plantar fascia with the intervention group receiving a combination of a conventional exercise program plus percutaneous electrolysis applied to both the plantar fascia and the myofascial trigger points in the gastrosoleus muscles.",[27],"2025-12-07",{"date":290,"type":37},"2025-12-19",{"date":292,"type":37},"2025-11-01",{"date":294,"type":21},"2026-04-10",{"name":296,"class":44},"Sivas State Hospital",{"id":298,"slug":299,"hasResults":11,"nctId":300,"briefTitle":301,"officialTitle":302,"acronym":303,"eligibilityCriteria":304,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":305,"enrollmentInfo":306,"targetDuration":4,"studyType":22,"phases":308,"briefSummary":309,"conditions":310,"keywords":311,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":313,"lastUpdatePostDateStruct":314,"startDateStruct":316,"completionDateStruct":318,"leadSponsor":320,"locationsCount":45},"100611603","bone-marrow-aspirate-versus-platelet-rich-fibrin-for-the-treatment-of-chronic-plantar-fasciitis-100611603","NCT07242729","Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Chronic Plantar Fasciitis","Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Plantar Fasciitis - A Double-Blind Randomized Clinical Trial","fasciitis","Inclusion Criteria:\n\n* Adults aged 18 to 75 years.\n* Clinical diagnosis of chronic plantar fasciitis for more than 6 months, confirmed by ultrasonography (increased plantar fascia thickness and hypoechogenicity).\n* Persistent heel pain refractory to conventional conservative treatment (stretching, orthotics, physical therapy, or corticosteroid injections).\n* Visual Analog Scale (VAS) pain score ≥ 4 at baseline.\n* Ability and willingness to comply with study procedures and follow-up assessments.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Previous foot or ankle surgery on the affected limb.\n* Acute trauma, infection, or ulceration in the region of the plantar fascia.\n* Systemic inflammatory diseases (e.g., rheumatoid arthritis, lupus, psoriatic arthritis).\n* Metabolic or endocrine disorders interfering with healing (e.g., diabetes mellitus with poor glycemic control, thyroid disorders).\n* Current use of systemic corticosteroids, immunosuppressants, or anticoagulants.\n* Active neoplasia or hematologic disorders.\n* Pregnancy or breastfeeding.\n* Peripheral vascular disease or neuropathy affecting the lower limbs.\n* Contraindications to local anesthesia or venipuncture.","75 Years",{"count":307,"type":21},72,[24],"This randomized, double-blind clinical trial aims to compare the clinical and imaging effects of autologous bone marrow aspirate versus platelet-rich fibrin injections in patients with chronic plantar fasciitis. The procedures are performed under ultrasound guidance to ensure precision and safety. The study evaluates pain reduction, foot function, and ultrasonographic changes in the plantar fascia at follow-up intervals.",[27],[312],"Plantar Fasciitis; Bone Marrow Aspirate; Platelet-Rich Fibrin; Ultrasound-Guided Injection; Regenerative Medicine","2025-11-17",{"date":315,"type":37},"2025-11-21",{"date":317,"type":37},"2025-02-01",{"date":319,"type":21},"2028-02-01",{"name":321,"class":44},"Federal University of São Paulo",{"id":323,"slug":324,"hasResults":11,"nctId":325,"briefTitle":326,"officialTitle":326,"acronym":4,"eligibilityCriteria":327,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":305,"enrollmentInfo":328,"targetDuration":4,"studyType":22,"phases":330,"briefSummary":331,"conditions":332,"keywords":333,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":337,"lastUpdatePostDateStruct":338,"startDateStruct":340,"completionDateStruct":342,"leadSponsor":344,"locationsCount":4},"100610885","comparison-of-the-effectiveness-of-dextrose-prolotherapy-and-extracorporeal-shock-wave-therapy-eswt-in-plantar-fasciitis-100610885","NCT07233395","Comparison of the Effectiveness of Dextrose Prolotherapy and Extracorporeal Shock Wave Therapy (ESWT) in Plantar Fasciitis","Inclusion Criteria:\n\n* Diagnosis of plantar fasciitis\n\nAges 18 to 75 years\n\nBoth male and female participants\n\nHeel pain localized to the medial calcaneal tubercle for more than 3 months\n\nMorning first-step pain and pain increasing with daily loading\n\nWillingness to participate and provide written informed consent\n\nPatients presenting to Kanuni Sultan Süleyman Training and Research Hospital\n\nExclusion Criteria:\n\nCardiac pacemaker\n\nType 1 or Type 2 diabetes mellitus\n\nHistory of inflammatory rheumatic disease\n\nBleeding disorders\n\nUse of anticoagulant medications other than aspirin\n\nAllergy to dextrose\n\nPrevious foot or ankle surgery\n\nPeripheral neuropathy\n\nS1 radiculopathy in the same extremity\n\nLocal corticosteroid injection to the plantar fascia within the last 3 months\n\nESWT applied to the plantar fascia within the last 3 months\n\nPhysical therapy applied to the foot\u002Fankle in the last 3 months\n\nCognitive dysfunction\n\nActive infection at the planned injection site\n\n\\-",{"count":329,"type":21},60,[24],"Plantar fasciitis is a degeneration of the plantar aponeurosis and is the most common cause of heel pain (11-15%). Although seen in both sexes, plantar fasciitis is more common in women, usually unilateral and bilateral in 30% of cases . The most widely accepted view regarding the formation of plantar fasciitis is that it is a degenerative process caused by myxoid degeneration, microtears, collagen necrosis, and angiofibroblastic hyperplasia, resulting from repetitive microtrauma to the plantar fascia, particularly at the calcaneal insertion site. It is not inflammatory . The purpose of this study was to compare the effectiveness of prolotherapy, a regenerative treatment, and ESWT in the treatment of plantar fasciitis.",[27],[334,335,336],"Dextrose Prolotherapy","Extracorporeal Shock Wave Therapy (ESWT)","Physical Medicine and Rehabilitation","2025-11-14",{"date":339,"type":37},"2025-11-18",{"date":341,"type":21},"2025-11-15",{"date":343,"type":21},"2026-03-15",{"name":345,"class":44},"Kanuni Sultan Suleyman Training and Research Hospital",{"id":347,"slug":348,"hasResults":11,"nctId":349,"briefTitle":350,"officialTitle":351,"acronym":4,"eligibilityCriteria":352,"healthyVolunteers":11,"sex":16,"minAge":353,"maxAge":55,"enrollmentInfo":354,"targetDuration":4,"studyType":22,"phases":356,"briefSummary":357,"conditions":358,"keywords":359,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":362,"lastUpdatePostDateStruct":363,"startDateStruct":365,"completionDateStruct":367,"leadSponsor":369,"locationsCount":4},"100606754","comparing-neural-mobilization-and-traditional-physiotherapy-in-plantar-fasciitis-patients-100606754","NCT07179666","Comparing Neural Mobilization and Traditional Physiotherapy in Plantar Fasciitis Patients","Effectiveness of Neural Mobilization in Patients With Planter Fasciitis: A Pilot Study","Inclusion Criteria:\n\n* Participants will be selected within the age range of 19 to 40 years\n* Meet the diagnostic criteria for plantar fasciitis, including symptoms of first-step pain in the morning and heel pain after long periods of standing, confirmed through clinical examination.\n\nExclusion Criteria:\n\n* Individuals will be omitted from the study if they have undergone foot or ankle or foot surgery during the prior 12 months\n* The presence of severe osteoarthritis, diabetic foot ulcers, or neuropathy","19 Years",{"count":355,"type":21},12,[24],"To evaluate the short-term effectiveness of neural mobilization targeting the posterior tibial nerve compared to traditional physiotherapy in cases diagnosed with plantar fasciitis, a pilot study will be conducted on 12 patients who will have been diagnosed with plantar fasciitis. Participants will be randomly divided into either the neural mobilization group or the conventional physiotherapy group, and all will receive three weeks of structured treatment. Results will be evaluated using techniques that will measure plantar pressure with Algometry, Foot Function Index (FFI) scores, and the Foot Health Status Questionnaire (FHSQ). Differences before and after treatment will be tested within the group using paired t-tests, and others will be examined between the groups with independent t-tests.",[27],[360,361],"neural moblization","conventional treatment","2025-09-11",{"date":364,"type":37},"2025-09-18",{"date":366,"type":21},"2025-09-12",{"date":368,"type":21},"2025-12-15",{"name":370,"class":44},"Gulf Medical University",{"id":372,"slug":373,"hasResults":11,"nctId":374,"briefTitle":375,"officialTitle":376,"acronym":4,"eligibilityCriteria":377,"healthyVolunteers":79,"sex":16,"minAge":17,"maxAge":378,"enrollmentInfo":379,"targetDuration":4,"studyType":22,"phases":380,"briefSummary":381,"conditions":382,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":383,"lastUpdatePostDateStruct":384,"startDateStruct":386,"completionDateStruct":388,"leadSponsor":390,"locationsCount":45},"100445020","the-effects-of-terrain-variation-on-intrinsic-foot-musculature-in-healthy-individuals-and-individuals-with-plantar-fasciitis-100445020","NCT05075005","The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis","A Randomized Control Trial Studying the Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis:","Inclusion Criteria for Group A:\n\n* Patients presenting to the University of Florida Orthopaedics and Sports Medicine Institute with pain on the plantar medial or central heel for greater than 60 days with the following features\n* Pain upon palpation, or insidious pain onset\n* Pain accentuated after long periods of weight bearing activities or after periods of rest\n* A reduction in pain following light activities (McPoil et al., 2008)\n* Failure to respond to treatment modalities for 6 months, including plantar fascia and muscle stretching, nonsteroidal anti-inflammatory medication, supportive insoles, and night splints\n* Age \\>18 years\n\nInclusion Criteria for Group B:\n\n* Healthy individuals in the general population of Gainesville and surrounding areas\n* Age \\>18\n\nExclusion Criteria for Group A:\n\n* History of lower leg or foot surgery, hindfoot trauma or fracture of the affected limb within the previous year.\n* Diagnosis of diabetic neuropathy, fibromyalgia, neurological disease, Achilles tendinopathy, metatarsalgia, tarsal tunnel syndrome or heel pad syndrome\n* Body Mass Index (BMI) \\> 35\n* Currently taking or applying any anti-inflammatory medication or medication to control nerve pathology, prescription or over the counter\n* Third trimester pregnancy\n\nExclusion Criteria for Group B:\n\n* Any foot or lower limb pathology resulting in discomfort or gait limitation\n* Diagnosis of diabetic neuropathy, fibromyalgia, neurological disease\n* BMI \\>35\n* Currently taking or applying any anti-inflammatory medication or medication to control nerve pathology, prescription or over the counter\n* Third trimester pregnancy","100 Years",{"count":329,"type":21},[24],"Modern footwear has been implicated as a contributor to foot pathology and changes in the biomechanics of gait. In addition to footwear, the investigators propose that the lack of terrain variation may directly contribute to the development of common foot pathologies, resulting from decreased intrinsic foot muscle function. This study will examine the current understanding of terrain variation on foot musculature strength and its possible correlation with structural and functional changes within the foot.",[27],"2025-08-27",{"date":385,"type":37},"2025-08-28",{"date":387,"type":37},"2022-07-15",{"date":389,"type":21},"2026-08-20",{"name":391,"class":44},"University of Florida",{"id":393,"slug":394,"hasResults":11,"nctId":395,"briefTitle":396,"officialTitle":397,"acronym":4,"eligibilityCriteria":398,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":399,"targetDuration":4,"studyType":82,"phases":4,"briefSummary":401,"conditions":402,"keywords":403,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":407,"lastUpdatePostDateStruct":408,"startDateStruct":410,"completionDateStruct":412,"leadSponsor":413,"locationsCount":45},"100597362","pain-and-fascia-thickness-after-steroid-injection-in-plantar-fasciitis-100597362","NCT07057505","Pain and Fascia Thickness After Steroid Injection in Plantar Fasciitis","Assesment of Pain, Foot Function, and Ultrasonographic Evaluation of Plantar Fascia Thickness in Patients Treated With Local Corticosteroid Injection for Plantar Fasciitis","Inclusion Criteria:\n\n* Patients who were clinically diagnosed with plantar fasciitis and received corticosteroid injections\n\nExclusion Criteria:\n\n* Pregnancy\n* Patients who have had more than one corticosteroid injection in the last 6 months\n* Patients with systemic inflammatory diseases\n* Patients who have previously undergone surgery in the heel area\n* Patients with a history of local trauma",{"count":400,"type":21},33,"The aim of this study is to evaluate the effects of local corticosteroid injection on pain, foot function index, and plantar fascia thickness in patients clinically diagnosed with plantar fasciitis, and to determine whether local corticosteroid injection is an appropriate treatment option for plantar fasciitis. For this purpose, the study plans to assess plantar fascia thickness using ultrasonography, evaluate pain using the Visual Analog Scale (VAS), and investigate the impact on daily living activities in patients who have been clinically diagnosed with plantar fasciitis and treated with local corticosteroid injections.",[27],[86,404,405,406],"plantar fascia thickness","ultrasonographic evaluation","injection","2025-07-15",{"date":409,"type":37},"2025-07-18",{"date":411,"type":21},"2025-08-01",{"date":271,"type":21},{"name":414,"class":415},"Istanbul Physical Medicine Rehabilitation Training and Research Hospital","OTHER_GOV",{"id":417,"slug":418,"hasResults":11,"nctId":419,"briefTitle":420,"officialTitle":420,"acronym":421,"eligibilityCriteria":422,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":130,"enrollmentInfo":423,"targetDuration":4,"studyType":22,"phases":424,"briefSummary":425,"conditions":426,"keywords":4,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":427,"lastUpdatePostDateStruct":428,"startDateStruct":430,"completionDateStruct":432,"leadSponsor":434,"locationsCount":4},"100597581","estimating-the-prevalence-of-gastrocnemius-muscle-retraction-in-a-population-suffering-from-plantar-aponeurositis-and-describing-the-effects-of-lengthening-100597581","NCT07060352","Estimating the Prevalence of GAstrocnemius Muscle REtraction in a Population Suffering From Plantar aPOneurositis and Describing the Effects of Lengthening","REGAPOP","Inclusion Criteria:\n\n* Patient aged 70 or under\n* Patient suffering from unilateral plantar fasciitis that has progressed for more than 6 months and is recalcitrant to medical treatment\n* Collection of express, oral consent\n* Available for follow-up visits\n\nExclusion Criteria:\n\n* Patients with neuropathic pain\n* History of fracture of the lower limb, surgery on the lower limb, inflammatory rheumatism of the lower limb, injury to the Achilles tendon\n* Patient with another painful orthopedic lesion of the legs\u002Ffeet\n* Patient with surgically treated plantar fasciitis in the year prior to inclusion\n* Persons unable to give consent\n* Not affiliated to a social security scheme\n* Persons under court protection\n* Participant in another study with an ongoing exclusion period",{"count":191,"type":21},[24],"The gastrocnemius muscles, which form the upper part of the calf, can suffer from retraction, a common but often under-diagnosed condition, which can be a risk factor for plantar fasciitis. Retraction can be treated medically, by stretching, or surgically, by lengthening the muscles. Gastrocnemius retraction is difficult to measure, but tests such as the Ankle Dorsiflexion Index (ADI) provide a more accurate assessment.\n\nKnowing the prevalence of this retraction in patients suffering from plantar fasciitis would enable us to improve diagnostic criteria and better target treatments. Surgical lengthening of the gastrocnemius, particularly by tenotomy, is effective in cases of chronic plantar fasciitis, even without apparent muscle retraction.",[27],"2025-07-01",{"date":429,"type":37},"2025-07-11",{"date":431,"type":21},"2025-09-01",{"date":433,"type":21},"2029-03-01",{"name":435,"class":44},"Clinique Saint Charles",{"id":437,"slug":438,"hasResults":11,"nctId":439,"briefTitle":440,"officialTitle":441,"acronym":442,"eligibilityCriteria":443,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":444,"targetDuration":4,"studyType":22,"phases":445,"briefSummary":446,"conditions":447,"keywords":448,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":457,"lastUpdatePostDateStruct":458,"startDateStruct":460,"completionDateStruct":462,"leadSponsor":464,"locationsCount":45},"100590419","heel-pain-pathways-feasibility-study-100590419","NCT06967168","HeEL Pain Pathways Feasibility Study","Feasibility of Developing Personalised Treatment Pathways for Relief of Plantar Heel Pain Using a Sequential Multiple Assignment Randomised Trial (SMART) Study Design","HELPP","Inclusion Criteria:\n\n* Adults aged 18 years or over\n* Have symptomatic heel pain (in one or both feet)\n* Able to speak, read and understand written and spoken English or Welsh\n* Able to provide remote informed consent\n* Access to internet and email, or DVD player, with technical support from family, friends or carers if necessary.\n\nExclusion Criteria:\n\n* Taken part in a prescribed exercise intervention or used prescribed insoles (past 3 months)\n* History of major trauma or fracture of the lower leg or below ankle surgery\n* Heel pain secondary to a systemic condition\u002Fsyndrome\u002Fmalignancy\n* Requires ankle-foot orthoses or lower limb device (splint)\n* Diabetes or peripheral neuropathy\n* History of inflammatory joint disease or autoimmune condition\n* Chronic pain syndrome\n* Pregnancy\n* Pacemaker or other electrical implant\n* Blood clotting disorder (haemophilia), blood clot (thrombosis), or current use of anticoagulant medication\n* Cortisone injection therapy within the last two weeks\n* Unable to complete exercises in self-help resources.",{"count":284,"type":21},[24],"At the moment, no-one is sure what the best way to treat heel pain is. The purpose of this research is to try out some study methods to prepare for a future clinical trial, that will assess how helpful combining different treatments are for people with heel pain (plantar fasciitis). At this stage, the aim is only to test the study processes and ask for feedback - that is why this is called a feasibility study. No experimental techniques or devices will be tested. All of the treatments in the study are routinely carried out in NHS clinics, but participants will be allocated to different combinations of treatments.\n\nEach participant will be asked to complete questionnaires and a diary for around six months in total. Some people will also be invited to take part in an interview or focus group discussion.",[27],[449,450,451,452,453,454,455,456],"pain management","podiatry","musculoskeletal diseases","foot diseases","foot orthoses","extracorporeal shockwave therapy","conservative treatment","self care","2025-05-08",{"date":459,"type":37},"2025-05-13",{"date":461,"type":37},"2024-09-02",{"date":463,"type":21},"2025-11-28",{"name":465,"class":415},"Cardiff and Vale University Health Board",{"id":467,"slug":468,"hasResults":11,"nctId":469,"briefTitle":470,"officialTitle":471,"acronym":4,"eligibilityCriteria":472,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":473,"enrollmentInfo":474,"targetDuration":4,"studyType":22,"phases":476,"briefSummary":477,"conditions":478,"keywords":479,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":483,"lastUpdatePostDateStruct":484,"startDateStruct":486,"completionDateStruct":488,"leadSponsor":490,"locationsCount":492},"100224198","botulinum-toxin-a-versus-steroids-for-the-treatment-of-chronic-plantar-fasciitis-100224198","NCT02196155","Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis","Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar Fasciitis: a Randomized Controlled Study","Inclusion Criteria:\n\n* Clinical symptoms of a plantar fasciitis\n* Plantar fasciitis in MRI\n* Exclusion of differential diagnoses\n* Symptoms more than 3 months\n* Absolution of 3 months unsuccessful treatment\n* Written informed consent\n\nExclusion Criteria\n\n* Active differential diagnoses\n* Contraindications: pregnancy and breastfeeding, infection at injection sites, allergy against BTX-A\n* Previous injections or surgery for plantar fasciitis\n* Neurological diseases affecting the peripheral nervous system","60 Years",{"count":475,"type":21},54,[24],"Plantar fasciitis is the classic and most common type of heel pain. Considering the costs for health care and the temporary disability not only for work, plantar fasciitis results in a substantial (and at least partially unnecessary) burden for the Swiss health care system and national economics.\n\nNonoperative treatment is the mainstay of treating plantar fasciitis. However, so far no treatment has proven to be superior to others, and there is national and international lack of consensus of how to treat plantar fasciitis best.\n\nThe investigators believe that the BTX-A injection in the gastrocnemius and the soleus muscles is currently the most promising non-operative approach, because it is considered to treat the disease at its origin (temporary weakening of the tight triceps surae muscle) as opposed to simply alleviate the symptoms (e.g. plantar cortisone and other injections, ESWT).\n\nHowever, to date there is no evidence in the literature that compares the new, promising technique of BTX-A injection into the gastroc-soleus complex to a sham (saline) injection and to the gold standard steroid injection at the plantar fascia insertion site. With the intended study, this gap is going to be closed.",[27],[86,480,481,482],"Botulinum toxin A","Cortisone","RCT","2024-12-09",{"date":485,"type":37},"2024-12-10",{"date":487,"type":37},"2016-07",{"date":489,"type":21},"2026-12",{"name":491,"class":44},"Insel Gruppe AG, University Hospital Bern",2,{"id":494,"slug":495,"hasResults":11,"nctId":496,"briefTitle":497,"officialTitle":498,"acronym":499,"eligibilityCriteria":500,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":473,"enrollmentInfo":501,"targetDuration":4,"studyType":22,"phases":503,"briefSummary":504,"conditions":505,"keywords":506,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":510,"lastUpdatePostDateStruct":511,"startDateStruct":513,"completionDateStruct":515,"leadSponsor":517,"locationsCount":45},"100567954","electrolysis-in-patients-with-chronic-plantar-fasciitis-100567954","NCT06674902","Electrolysis in Patients With Chronic Plantar Fasciitis","Short-term Effectiveness of High- and Low-intensity Percutaneous Electrolysis in Patients With Plantar Fasciitis","Electrolysis","Inclusion Criteria:\n\n* age 18 years or older,\n* unilateral heel pain lasting longer than 3 months,\n* a clinical diagnosis of chronic plantar fasciitis according to the clinical practice guidelines of the Orthopaedic Section of the American Physical Therapy Association (APTA), i.e., sudden onset of pain on the plantar surface of the heel after a period of non-weight bearing, pain that is worse in the morning with the first step, and tenderness to palpation at the proximal attachment site of the plantar fascia.\n\nExclusion Criteria:\n\n* previous lower extremity surgery,\n* the presence of positive neurological signs consistent with nerve root compression,\n* any medical conditions causing heel pain, such as rheumatoid arthritis, diabetes, or peripheral neuropathy,\n* receipt of any foot treatment within the past 6 weeks.",{"count":502,"type":21},16,[24],"Aim of the Study\n\nThe aim of this study is to investigate the differential effects of high-intensity and low-intensity percutaneous electrolysis (PCE) on pain perception and muscle tissue properties in individuals with chronic plantar fasciitis.\n\nResearch Questions\n\nPain Perception:\n\nDoes high-intensity PCE induce greater changes in pressure pain threshold (PPT) in the plantar fascia compared to low-intensity PCE in individuals with chronic plantar fasciitis?\n\nMuscle Tissue Properties:\n\nDoes high-intensity PCE reduce stiffness in the plantar fascia to a greater extent than low-intensity PCE in individuals with chronic plantar fasciitis?",[27],[507,499,508,509],"Pain","shear-wave elastography","pain sensitivity","2024-11-04",{"date":512,"type":37},"2024-11-05",{"date":514,"type":21},"2024-11-11",{"date":516,"type":21},"2024-11-30",{"name":518,"class":44},"Wroclaw University of Health and Sport Sciences",{"id":520,"slug":521,"hasResults":11,"nctId":522,"briefTitle":523,"officialTitle":523,"acronym":524,"eligibilityCriteria":525,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":526,"targetDuration":4,"studyType":22,"phases":527,"briefSummary":528,"conditions":529,"keywords":530,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":532,"lastUpdatePostDateStruct":533,"startDateStruct":535,"completionDateStruct":537,"leadSponsor":539,"locationsCount":45},"100561351","34comparison-of-shockwave-application-on-the-sole-of-the-foot-vs-the-back-of-the-leg-in-the-treatment-of-plantar-fasciitis-a-clinical-trial34-100561351","NCT06589037",""Comparison of Shockwave Application on the Sole of the Foot Vs. the Back of the Leg in the Treatment of Plantar Fasciitis: a Clinical Trial."","SW-PF-BL","Inclusion criteria: having been diagnosed with plantar fasciitis, experiencing pain related to the condition for at least 1 month, and being between 18 and 65 years of age.\n\nExclusion criteria: being pregnant, having a pacemaker, presenting with rheumatoid arthritis, or having coagulation disorders.",{"count":235,"type":21},[24],"The study focuses on plantar fasciitis, one of the most common causes of non-traumatic foot and ankle pain, with an estimated prevalence of 10%. Its objective is to evaluate the effectiveness of shock wave therapy applied along the course of the sciatic nerve in treating plantar fasciitis, comparing its effects on pain, foot-ankle functionality, and quality of life.\n\nForty-eight subjects will be recruited and randomly assigned to two groups: one will receive local shock wave therapy, while the other will receive therapy along the sciatic nerve. Data will be collected at four points in time: before the intervention, one week after, one month after, and three months after, with blinded data collection.\n\nPain, foot-ankle functionality, and quality of life will be measured. Data analysis will be performed using SPSS 29.0, applying ANOVA and other tests depending on the normality of the data. Differences will be estimated with a 95% confidence interval and a p-value \\< 0.05.",[27],[531],"plantar fasciitis, shockwaves, sciatic nerve.","2024-09-05",{"date":534,"type":37},"2024-09-19",{"date":536,"type":21},"2024-10-01",{"date":538,"type":21},"2025-05-01",{"name":540,"class":44},"University of Alcala",{"id":542,"slug":543,"hasResults":11,"nctId":544,"briefTitle":545,"officialTitle":546,"acronym":547,"eligibilityCriteria":548,"healthyVolunteers":79,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":549,"targetDuration":4,"studyType":22,"phases":551,"briefSummary":552,"conditions":553,"keywords":554,"overallStatus":113,"whyStopped":4,"lastUpdateSubmitDate":559,"lastUpdatePostDateStruct":560,"startDateStruct":562,"completionDateStruct":564,"leadSponsor":566,"locationsCount":4},"100559389","the-effect-of-insoles-in-plantar-fasciitis-100559389","NCT06563492","The Effect of Insoles in Plantar Fasciitis","The Effect of Insoles on Muscle Activation and Gait Parameters in Plantar Fasciitis","Insoles","Inclusion Criteria:\n\n* Being between the ages of 18-65,\n* Being diagnosed with plantar fasciitis,\n* Being prescribed custom insoles,\n* Having complaints for at least 3 months,\n* Heel pain complaint is at the plantar medial calcaneal tubercle,\n* Pain complaint is most evident in the first steps taken in the morning or in the steps after resting,\n* Having a Roles and Maudsley score of 3 or 4 in the initial evaluation\n\nExclusion Criteria:\n\n* Having a body mass index greater than 30 kg\u002Fm2,\n* Having any cardiopulmonary, dermatological, neurological or orthopedic problems other than plantar fasciitis,\n* Having a history of foot or ankle surgery,\n* Using an assistive device (walker, canadiens, etc.)\n* Not using appropriate shoes,\n* Having cognitive, mental and\u002For psychological problems\n* Being pregnant",{"count":550,"type":21},30,[24],"It aims to investigate the effect of two personalized insoles made of different materials designed to reduce pain in individuals with plantar fasciitis on muscle activation and gait parameters at 3-month follow-up.",[27],[86,555,556,557,558],"insole","EVA","3D printer","muscle activation","2024-08-21",{"date":561,"type":37},"2024-08-23",{"date":563,"type":21},"2024-09-16",{"date":565,"type":21},"2026-07-21",{"name":567,"class":44},"Medipol University"]